---
title: "Advance Purchase Agreement"
ocid: "ocds-h6vhtk-02ee22"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02ee22"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02ee22.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02ee22.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "BUSINESS ENERGY AND INDUSTRIAL STRATEGY"
published: "2021-10-20"
---

# Advance Purchase Agreement

Buyer: BUSINESS ENERGY AND INDUSTRIAL STRATEGY  
Current stage: Award  
OCID: ocds-h6vhtk-02ee22

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02ee22)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02ee22.json)

## Summary

The procurement process involves the Business Energy and Industrial Strategy, which is located in London, UK. The title of the tender is "Advance Purchase Agreement" and it falls under the goods category, specifically for vaccines (CPV code: 33651600). The procurement method was limited, with an award procedure conducted without prior publication of a call for competition, and the process is currently at the award stage. The contract, signed on 20th September 2021, is related to the procurement of the Covid-19 Adjuvanted Pandemic Vaccine, although contract values and contract end dates remain undisclosed due to commercial sensitivity.

This tender presents significant opportunities for businesses, particularly those in the pharmaceutical or healthcare sectors, capable of developing or supplying vaccines. Companies that can navigate the competitive landscape of vaccine provision and have the technical capability to meet the specifications outlined in this agreement would be well-positioned to engage. The involvement of major suppliers such as Aventis Pharma Ltd and GlaxoSmithKline Biologicals S.A. illustrates the scale and potential impact of this procurement process, encouraging other large-scale suppliers to consider similar engagements in future vaccine-related initiatives.

## Notice

Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.

### Lot Information

Lot 1

Procurement of the Covid-19 Adjuvanted Pandemic Vaccine. Additional information: Contract value is being withheld due to commercial sensitivity (PCR 2015 Reg 50(6)(b) and (c) and FOIA 2000 Section 43). Publication may enable competitors to calculate cost per dose. This will commercially prejudice: (i) the supplier in its negotiations with other national governments; and (ii) the contracting authority in negotiations with other vaccine vendors. It may also impact fair competition between vaccine vendors.

### Procurement Information

The award of the contract to Aventis Pharma and GSK is strictly necessary due to absence of competition for technical reasons. Regulation 32 (b)(ii). Furthermore, this Advance Purchase Agreement is the execution of the previous Capacity Reservation Agreement (Please see linked notice)

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/026293-2021 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 20 Oct 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 19 Sep 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | BUSINESS ENERGY AND INDUSTRIAL STRATEGY |
| Locality | LONDON |
| Post town | South West London |
| Postcode | SW1H 0ET |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI3 Inner London - West |
| ITL 3 | TLI35 Westminster and City of London |
| Local authority | Westminster |
| Electoral ward | St James's |
| Westminster constituency | Cities of London and Westminster |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 2 |
| Supplier names | AVENTIS PHARMA; GLAXOSMITHKLINE BIOLOGICALS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33651600 - Vaccines

## Release History

- 20 Oct 2021 at 15:33 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/026293-2021

## Notice URLs

- https://ted.europa.eu/udl?uri=TED:NOTICE:560526-2020:TEXT:EN:HTML
- https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02ee22. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02ee22.json.